Literature DB >> 27060105

Molecular and cellular basis for the unique functioning of Nrf1, an indispensable transcription factor for maintaining cell homoeostasis and organ integrity.

Yiguo Zhang1, Yuancai Xiang2.   

Abstract

The consensuscis-regulatory AP-1 (activator protein-1)-like AREs (antioxidant-response elements) and/or EpREs (electrophile-response elements) allow for differential recruitment of Nrf1 [NF-E2 (nuclear factor-erythroid 2)-related factor 1], Nrf2 and Nrf3, together with each of their heterodimeric partners (e.g. sMaf, c-Jun, JunD or c-Fos), to regulate different sets of cognate genes. Among them, NF-E2 p45 and Nrf3 are subject to tissue-specific expression in haemopoietic and placental cell lineages respectively. By contrast, Nrf1 and Nrf2 are two important transcription factors expressed ubiquitously in various vertebrate tissues and hence may elicit putative combinational or competitive functions. Nevertheless, they have de facto distinct biological activities because knockout of their genes in mice leads to distinguishable phenotypes. Of note, Nrf2 is dispensable during development and growth, albeit it is accepted as a master regulator of antioxidant, detoxification and cytoprotective genes against cellular stress. Relative to the water-soluble Nrf2, less attention has hitherto been drawn to the membrane-bound Nrf1, even though it has been shown to be indispensable for embryonic development and organ integrity. The biological discrepancy between Nrf1 and Nrf2 is determined by differences in both their primary structures and topovectorial subcellular locations, in which they are subjected to distinct post-translational processing so as to mediate differential expression of ARE-driven cytoprotective genes. In the present review, we focus on the molecular and cellular basis for Nrf1 and its isoforms, which together exert its essential functions for maintaining cellular homoeostasis, normal organ development and growth during life processes. Conversely, dysfunction of Nrf1 results in spontaneous development of non-alcoholic steatohepatitis, hepatoma, diabetes and neurodegenerative diseases in animal models.
© 2016 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Nrf1; Nrf2; cancer; diabetes; homoeostasis; organ integrity; redox stress; topobiology

Mesh:

Substances:

Year:  2016        PMID: 27060105     DOI: 10.1042/BJ20151182

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Developmental Regulation of Nuclear Factor Erythroid-2 Related Factors (nrfs) by AHR1b in Zebrafish (Danio rerio).

Authors:  Alexandra Ulin; Jake Henderson; Minh-Tam Pham; James Meyo; Yuying Chen; Sibel I Karchner; Jared V Goldstone; Mark E Hahn; Larissa M Williams
Journal:  Toxicol Sci       Date:  2019-02-01       Impact factor: 4.849

2.  A Phase I, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Tolerance of Oil Palm Phenolics (OPP) in Healthy Volunteers.

Authors:  Nur Balqis Muhammad Ismail Tadj; Nurul 'Izzah Ibrahim; Qodriyah Haji Mohd Saad; Tg Mohd Ikhwan Tg Abu Bakar Sidik; Soon-Sen Leow; Syed Fairus; Isa Naina Mohamed
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

3.  KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition.

Authors:  Michael S Binkley; Young-Jun Jeon; Monica Nesselbush; Everett J Moding; Barzin Y Nabet; Diego Almanza; Christian Kunder; Henning Stehr; Christopher H Yoo; Siyeon Rhee; Michael Xiang; Jacob J Chabon; Emily Hamilton; David M Kurtz; Linda Gojenola; Susie Grant Owen; Ryan B Ko; June Ho Shin; Peter G Maxim; Natalie S Lui; Leah M Backhus; Mark F Berry; Joseph B Shrager; Kavitha J Ramchandran; Sukhmani K Padda; Millie Das; Joel W Neal; Heather A Wakelee; Ash A Alizadeh; Billy W Loo; Maximilian Diehn
Journal:  Cancer Discov       Date:  2020-10-18       Impact factor: 38.272

4.  Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity.

Authors:  Frederick M Tomlin; Ulla I M Gerling-Driessen; Yi-Chang Liu; Ryan A Flynn; Janakiram R Vangala; Christian S Lentz; Sandra Clauder-Muenster; Petra Jakob; William F Mueller; Diana Ordoñez-Rueda; Malte Paulsen; Naoko Matsui; Deirdre Foley; Agnes Rafalko; Tadashi Suzuki; Matthew Bogyo; Lars M Steinmetz; Senthil K Radhakrishnan; Carolyn R Bertozzi
Journal:  ACS Cent Sci       Date:  2017-10-25       Impact factor: 14.553

Review 5.  Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease.

Authors:  Dan Lindholm; Laura Korhonen; Ove Eriksson; Sulev Kõks
Journal:  Front Cell Dev Biol       Date:  2017-05-10

Review 6.  Redox regulation of proteasome function.

Authors:  Maria Lefaki; Nikoletta Papaevgeniou; Niki Chondrogianni
Journal:  Redox Biol       Date:  2017-07-06       Impact factor: 11.799

7.  Effects of Aqueous Dispersions of C60, C70 and Gd@C82 Fullerenes on Genes Involved in Oxidative Stress and Anti-Inflammatory Pathways.

Authors:  Elena V Proskurnina; Ivan V Mikheev; Ekaterina A Savinova; Elizaveta S Ershova; Natalia N Veiko; Larisa V Kameneva; Olga A Dolgikh; Ivan V Rodionov; Mikhail A Proskurnin; Svetlana V Kostyuk
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

8.  TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.

Authors:  Meng Wang; Yonggang Ren; Shaofan Hu; Keli Liu; Lu Qiu; Yiguo Zhang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

9.  Forward genetic screens identify a role for the mitochondrial HER2 in E-2-hexenal responsiveness.

Authors:  Alessandra Scala; Rossana Mirabella; Joachim Goedhart; Michel de Vries; Michel A Haring; Robert C Schuurink
Journal:  Plant Mol Biol       Date:  2017-09-16       Impact factor: 4.076

10.  Changes of KEAP1/NRF2 and IKB/NF-κB Expression Levels Induced by Cell-Free DNA in Different Cell Types.

Authors:  Svetlana V Kostyuk; Lev N Porokhovnik; Elizaveta S Ershova; Elena M Malinovskaya; Marina S Konkova; Larisa V Kameneva; Olga A Dolgikh; Vladimir P Veiko; Vladimir M Pisarev; Andrew V Martynov; Vasilina A Sergeeva; Andrew A Kaliyanov; Anton D Filev; Julia M Chudakova; Margarita S Abramova; Serguey I Kutsev; Vera L Izhevskaya; Nataliya N Veiko
Journal:  Oxid Med Cell Longev       Date:  2018-03-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.